Osteoporosis Medications Flashcards
Bisphosphonates - indications
- Osteoporosis
- Paget disease of the bone
- Hypercalcemia
- Metastatic cancer: osteolytic bone lesion
Bisphosphonates - adverse effects
Esophageal erosion
Atypical femur fractures
Osteonecrosis of the jaw
Bisphosphonates - contraindications/precautions
severe GERD or esophagitis - use caution with oral formulations
creatinine clearance <30
hypocalcemia
Bisphosphonates - MOA
Absorb hydroxyapatite and become permanent parts of the bone structure (terminal half life is 10 years). Inhibits osteoclast activity by preventing them to attach to bone
Bisphosponate administration
Oral:
low bioavailability.
Taken in morning on empty stomach
Weekly or daily dosing
IV (ibandronate - q 3mos and zoledronic acid - yearly infusion)
flu like symptoms common after zolendronic acid infusion
Calcium supplementation - indications
Hypocalcemia Osteoporosis
Calcium supplements - interactions
Decreased absorption of ciprofloxacin, fluoride, phenytoin, levothyroxine, tetracycline, iron
Calcium supplements (2 drugs)
Calcium carbonate
Calcium citrate
How does calcium citrate differ from calcium carbonate?
It is not dependent on gastric acid for absorption, well suited for old people or pt using PPIs
Vit D recommended daily allowance for over 50 years old
600units (max 4000units)
What other drugs may protect bones (apart from supplements and bisphosphonates)?
Raloxifene (SERM)
Calcitonin
Denosumab
Teriparatide
Raloxifene - MOA
Activates estrogen receptors in bone while having antiestrogen effects in breast and uterine tissues
Raloxifene - adverse effects
Intensify postmenopausal symptoms (hot flashes)
DVT Stroke, pulmonary embolism
leg cramps
Raloxifene - indications
Postmenopausal osteoporosis, especially in women at high risk for breast cancer
Calcitonin nasal spray adverse effects
nasal stuffiness
increased cancer risk